Valuation
- Market cap
- 57,960,000
- Revenue TTM
- $810,000
- Net income TTM
- $-45,310,000
- PE ratio
- 0.00
- Forward PE
- 0.44
- Profit margin
- -5,593.83%
- Debt to equity
- 0.08
Trading
- Volume
- 534,300
- Avg volume
- 506,994
- Day's range
- $3.70 – $3.95
- Shares out
- 15,539,000
- Stochastic %K
- 18%
- Beta
- 2.51
- Analysts
- Strong Sell
- Price target
- $9.82
Company profile
Hyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem. It is also developing the Optejet User Filled Device to work with various topical ophthalmic liquids, including artificial tears...
Show more
Hyperion DeFi, Inc., a DeFi company, engages in building on Hyperliquid. It operates through two segments: Ophthalmic Technology and Digital Assets. The company focuses on the long-term strategic treasury of HYPE tokens to provide simplified exposure to the Hyperliquid blockchain ecosystem. It is also developing the Optejet User Filled Device to work with various topical ophthalmic liquids, including artificial tears and lens rewetting products. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is based in Dallas, Texas.
- Industry
- Biotechnology
- Sector
- Healthcare
- Phone
- 833 393 6684
- Website
- https://hyperiondefi.com
- Address
- 3090 Nowitzki Way, Suite 300, Dallas, United States
Latest news
No headlines yet.
